Showing results (801-810 of 1,006) with videos related to
Sort By:
Pageof 101
Ejhaem|October 16, 2025
B/T Mixed Phenotype Acute Leukaemia Harbouring NUP98::BPTF FusionVan Tuong Nguyen, Lina Han, Jing Xu, et al.Ejhaem|July 30, 2025
Rapid Identification of DUX4::IGH Fusion in Acute Lymphoblastic LeukemiaKyoko Moritani, Minenori Eguchi-Ishimae, Mari Tezuka-Kagajo, et al.Ejhaem|July 25, 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to TransplantErin A Dean, Rick Y Lin, Tuo Lin, et al.Ejhaem|December 5, 2022
Aggressive, early resistant and relapsed mantle cell lymphoma distinct extrinsic microenvironment highlighted by transcriptome analysisYannick Le Bris, Adeline Normand, Louise Bouard, et al.Ejhaem|December 5, 2022
Normalization of NPM1 mutant transcript to the wild-type transcriptLawrence J JenningsEjhaem|December 5, 2022
Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective studySimon J Bulley, Anna Santarsieri, Isabel C Lentell, et al.Ejhaem|December 5, 2022
Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, ArboFiras Safa, Terri Rasmussen, Patricia Lobelle-Rich, et al.Ejhaem|December 5, 2022
De-escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open-label, prospective trial in ChinaJie Luo, Xin Du, Jin Lou, et al.Ejhaem|December 5, 2022
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosisNaveen Pemmaraju, Claire Harrison, Vikas Gupta, et al.Ejhaem|December 5, 2022
Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case reportJad Sibai, RuiQi Chen, Ibrahim Al Nabhani, et al.Pageof 101